Alvesco Use During Pregnancy

is alvesco safe during pregnancy

Alvesco is a brand-name aerosol inhaler prescribed to help prevent symptoms of asthma. It contains the active drug ciclesonide and belongs to the corticosteroid drug class. It is not known if Alvesco is safe to use during pregnancy. There have not been any studies to determine whether Alvesco is safe for use while pregnant. However, studies in animals have shown that pregnant animals given an injectable form of Alvesco did experience miscarriage and their offspring had cleft palate and problems with bone formation.

shunchild

Animal studies on ciclesonide

Animal studies have been conducted to investigate the metabolism of ciclesonide, a corticosteroid used to treat asthma and allergic rhinitis. In these studies, ciclesonide was administered to animals, and its uptake, activation, and metabolism were evaluated in various tissues, including the nasal mucosa, liver, and lungs.

In one study, ciclesonide was administered to rabbits, rats, guinea pigs, and dogs, and its metabolism in nasal mucosal homogenates was examined. The results showed that ciclesonide was effectively metabolized in all species, with no significant differences observed among them.

Another study compared the metabolism of ciclesonide in human liver microsomes with that of other corticosteroids. It was found that ciclesonide was primarily metabolized by esterases and then further processed by CYP3A4.

The activation and metabolism of ciclesonide have also been studied in human lung tissue slices and human nasal epithelial cells. These studies revealed that ciclesonide was rapidly taken up and converted to its active metabolite, desisobutyryl-ciclesonide (des-CIC), by intracellular airway esterases. The formation of des-CIC fatty acid esters, which serve as a slow-release pool of the active drug, was also observed. This reversible esterification process may contribute to the proven efficacy of once-daily inhaled ciclesonide in asthma therapy.

Furthermore, the effect of different protein concentrations on the uptake and metabolism of ciclesonide was investigated. It was found that higher serum protein concentrations reduced the uptake of des-CIC into human hepatocytes compared to budesonide. However, at all corticosteroid concentrations and serum levels tested, the uptake of des-CIC was significantly greater than that of budesonide.

Overall, these animal studies provide valuable insights into the metabolism and pharmacokinetics of ciclesonide, contributing to our understanding of its efficacy and safety profile in the treatment of asthma and allergic rhinitis.

Virgin Mojitos: Safe Pregnancy Treat?

You may want to see also

shunchild

Risk to the foetus

It is not known if Alvesco is safe to use during pregnancy. There have been no studies to determine whether Alvesco is safe for use while pregnant. However, there are some risks to the foetus that have been identified.

Alvesco is a brand-name aerosol inhaler that contains the active drug ciclesonide and belongs to the corticosteroid drug class. It is prescribed to help prevent symptoms of asthma in adults and children aged 12 years and older. While it is not known to cause any harm to the foetus, there are some potential risks that should be considered.

Firstly, animal studies have shown that subcutaneous administration of ciclesonide produced fetal toxicity. There are no well-controlled studies in pregnant women, but the potential benefits may outweigh the risks in certain cases. The US FDA pregnancy category for ciclesonide is C, indicating that animal reproduction studies have shown an adverse effect on the fetus and there are no adequate studies in humans. Therefore, the use of Alvesco during pregnancy should be carefully evaluated, and the potential benefits should outweigh the potential risks to the fetus.

Secondly, infants born to mothers who received corticosteroids during pregnancy may experience hypoadrenalism. This means that their adrenal glands may not produce enough hormones, and they should be carefully monitored.

Additionally, there is some data suggesting that the use of inhaled corticosteroids (ICSs), including Alvesco, may slightly increase the chance of miscarriage. However, the risk may vary depending on the exact medication, and there can be many other causes of miscarriage.

Furthermore, while ICSs have not been found to increase the overall chance of birth defects, high doses of ICSs (closer to the doses found in corticosteroid pills) have not been well studied during pregnancy. It is important to note that ICSs are considered the preferred asthma treatment during pregnancy as they control asthma effectively and are absorbed into the body in lower amounts compared to pill or tablet forms.

In conclusion, while there is no definitive evidence that Alvesco is harmful to the foetus, it is important for pregnant women or those planning to become pregnant to consult their healthcare providers before using this medication. The benefits and risks should be carefully weighed, and proper patient education on ICS administration and adherence during pregnancy is crucial.

Myo-Inositol: Safe Pregnancy Support?

You may want to see also

shunchild

Pregnancy and breastfeeding warnings

Alvesco (ciclesonide) is a brand-name aerosol inhaler prescribed to help prevent symptoms of asthma. It is not known if Alvesco is safe to use during pregnancy. There have not been any studies to determine whether Alvesco is safe for use while pregnant. However, in studies of pregnant animals, those given Alvesco by mouth did not have any increased risk of birth defects in their offspring. But pregnant animals given an injectable form of Alvesco did experience miscarriage, and their offspring had cleft palate and problems with bone formation. It is important to note that studies in animals do not always indicate what will happen in humans.

If you are pregnant or planning to become pregnant, talk to your doctor before using Alvesco. They can advise you on the pros and cons of the medication and help you weigh the potential benefits against the risks to the fetus.

It is also not known if Alvesco is safe to use while breastfeeding. In clinical trials of other corticosteroids, the corticosteroids were present in breast milk. However, it is unclear if Alvesco is also present in breast milk. In animal studies, small amounts of Alvesco were present in the breast milk of lactating animals, but animal studies do not always indicate what will happen in humans.

If you are breastfeeding or planning to breastfeed, consult your doctor before starting Alvesco treatment. They can advise you on the potential benefits and risks of the medication.

shunchild

ICSs as a preferred asthma treatment

ICSs are the most effective controllers of asthma and are the only drugs that can effectively suppress inflammation in asthmatic airways. They are the first-line therapy for all patients with persistent asthma, controlling asthma symptoms and preventing exacerbations. ICSs are now recommended as first-line therapy for all patients with persistent symptoms. ICSs should be started in any patient who needs to use a β2-agonist inhaler for symptom control more than three times weekly. ICSs are also considered safe during pregnancy.

Inhaled corticosteroids (ICSs) are the most effective medications available for patients with persistent asthma of all severities. ICSs suppress the expression and/or effects of multiple inflammatory molecules that are active in asthma. They are the most effective anti-inflammatory therapy for asthma, reducing airway hyperresponsiveness and controlling asthma symptoms. ICSs are the only maintenance therapy known to prevent asthma death.

ICSs are now recommended as first-line therapy for all patients with persistent disease. ICSs should be started in any patient who needs to use a β2-agonist inhaler for symptom control more than three times a week. ICSs are also considered safe during pregnancy.

ICSs have minimal systemic effects in most patients when taken at recommended doses. The benefits of ICS therapy clearly outweigh the risks of uncontrolled asthma, and ICSs should be prescribed routinely as first-line therapy for children and adults with persistent disease.

ICSs are the core component of asthma treatment. ICSs are the most effective anti-inflammatory therapy for asthma, suppressing the expression and/or effects of multiple inflammatory molecules that are active in asthma. ICSs reduce airway hyperresponsiveness and control asthma symptoms. ICSs are the only maintenance therapy known to prevent asthma death.

ICSs are the most effective controllers of asthma and are the only drugs that can effectively suppress inflammation in asthmatic airways. ICSs are first-line therapy for all patients with persistent asthma, controlling asthma symptoms and preventing exacerbations. ICSs are also considered safe during pregnancy.

ICSs are the most effective treatment for asthma and are the only drugs that can effectively suppress inflammation in asthmatic airways. ICSs are the first-line therapy for all patients with persistent asthma, controlling asthma symptoms and preventing exacerbations. ICSs are also considered safe during pregnancy.

shunchild

Oral corticosteroids and risks

Corticosteroids are a group of medications that prevent or suppress inflammation and immune responses. They are often necessary to control the symptoms of various medical conditions during pregnancy, including rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease.

Oral corticosteroids like prednisone or prednisolone have been associated with an increased chance of preterm delivery (birth before week 37) and/or low birth weight. However, since corticosteroids are used to treat medical conditions that can increase the chance of preterm delivery and low birth weight, these effects may be related to the illnesses being treated and not the medications alone.

Older studies have also suggested a small increased chance for having a baby with a cleft lip, with or without a cleft palate, following the use of oral corticosteroids during the first trimester. However, newer studies and further reviews of older studies do not support this finding. If there is an increased chance, it appears to be very small and most pregnancies would not be affected.

The use of oral corticosteroids during pregnancy has also been associated with a slight increase in the risk of preterm birth. One study of people with systemic lupus erythematosis showed that those with active lupus who took more than 10 milligrams of prednisone per day had an increased risk of preterm delivery. However, another study of pregnant people with inflammatory bowel disease showed that prednisone did not have any significant effect on preterm delivery.

In summary, there may be a modest increase in the risk of cleft lip with or without cleft palate from oral corticosteroid use during pregnancy, but data are conflicting, and it is unknown to what extent maternal disease contributes to this risk. There is little evidence that oral corticosteroid use during pregnancy independently increases the risks of preterm birth, low birth weight, or preeclampsia.

Frequently asked questions

It is not known if Alvesco is safe to use during pregnancy as there haven't been any studies to determine this. However, in studies of pregnant animals, those given Alvesco by mouth didn't have any increased risk of birth defects in their offspring.

Alvesco is a brand-name aerosol inhaler prescribed to help prevent symptoms of asthma. It contains the active drug ciclesonide and belongs to the corticosteroid drug class.

Alvesco can cause mild or serious side effects. Mild side effects may include nasal congestion, upper respiratory infection, back, arm, or leg pain, swelling in the nose or throat, sinusitis, and oral thrush. Serious side effects include an increased level of cortisol in the blood, increased risk of infection, decreased bone mineral density, bronchospasm, and eye conditions such as glaucoma.

You should not stop taking Alvesco without first talking to your doctor. If you suddenly stop using your Alvesco inhaler, your asthma symptoms could return.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment